Private Trust Company’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $991K | Sell |
6,324
-70
| -1% | -$10.5K | 0.08% | 279 |
|
|
2026
Q1 | $977K | Buy |
6,394
+108
| +2% | +$16.6K | 0.09% | 260 |
|
|
2025
Q4 | $867K | Buy |
6,286
+206
| +3% | +$27K | 0.08% | 289 |
|
|
2025
Q3 | $780K | Buy |
6,080
+189
| +3% | +$23.1K | 0.07% | 310 |
|
|
2025
Q2 | $713K | Buy |
5,891
+357
| +6% | +$40.2K | 0.07% | 311 |
|
|
2025
Q1 | $617K | Buy |
5,534
+358
| +7% | +$38.1K | 0.06% | 331 |
|
|
2024
Q4 | $504K | Buy |
5,176
+355
| +7% | +$37.9K | 0.05% | 376 |
|
|
2024
Q3 | $555K | Buy |
4,821
+355
| +8% | +$40.3K | 0.06% | 361 |
|
|
2024
Q2 | $475K | Sell |
4,466
-638
| -13% | -$64K | 0.05% | 384 |
|
|
2024
Q1 | $494K | Buy |
5,104
+12
| +0.2% | +$1.23K | 0.05% | 363 |
|
|
2023
Q4 | $514K | Buy |
5,092
+465
| +10% | +$44.9K | 0.06% | 335 |
|
|
2023
Q3 | $471K | Sell |
4,627
-148
| -3% | -$15K | 0.06% | 329 |
|
|
2023
Q2 | $482K | Buy |
4,775
+664
| +16% | +$66.4K | 0.06% | 325 |
|
|
2023
Q1 | $378K | Buy |
4,111
+663
| +19% | +$57.9K | 0.05% | 379 |
|
|
2022
Q4 | $313K | Sell |
3,448
-166
| -5% | -$14K | 0.05% | 405 |
|
|
2022
Q3 | $275K | Sell |
3,614
-216
| -6% | -$17.9K | 0.04% | 411 |
|
|
2022
Q2 | $324K | Sell |
3,830
-220
| -5% | -$19.3K | 0.05% | 373 |
|
|
2022
Q1 | $355K | Sell |
4,050
-95
| -2% | -$8.22K | 0.06% | 271 |
|
|
2021
Q4 | $363K | Sell |
4,145
-272
| -6% | -$22.6K | 0.05% | 301 |
|
|
2021
Q3 | $361K | Buy |
4,417
+1,122
| +34% | +$101K | 0.05% | 313 |
|
|
2021
Q2 | $301K | Sell |
3,295
-148
| -4% | -$13.2K | 0.05% | 335 |
|
|
2021
Q1 | $294K | Sell |
3,443
-160
| -4% | -$14.4K | 0.05% | 340 |
|
|
2020
Q4 | $340K | Buy |
3,603
+500
| +16% | +$43.7K | 0.06% | 290 |
|
|
2020
Q3 | $269K | Sell |
3,103
-1,684
| -35% | -$146K | 0.05% | 306 |
|
|
2020
Q2 | $423K | Buy |
4,787
+1,479
| +45% | +$128K | 0.09% | 240 |
|
|
2020
Q1 | $272K | Buy |
3,308
+71
| +2% | +$6.33K | 0.07% | 278 |
|
|
2019
Q4 | $306K | Buy |
3,237
+21
| +0.7% | +$1.88K | 0.06% | 304 |
|
|
2019
Q3 | $279K | Sell |
3,216
-280
| -8% | -$25.1K | 0.06% | 304 |
|
|
2019
Q2 | $319K | Sell |
3,496
-79
| -2% | -$6.69K | 0.06% | 283 |
|
|
2019
Q1 | $307K | Buy |
3,575
+9
| +0.3% | +$723 | 0.06% | 291 |
|
|
2018
Q4 | $274K | Sell |
3,566
-55
| -2% | -$4.28K | 0.07% | 288 |
|
|
2018
Q3 | $279K | Sell |
3,621
-240
| -6% | -$17.7K | 0.06% | 310 |
|
|
2018
Q2 | $261K | Buy |
3,861
+183
| +5% | +$12.6K | 0.06% | 319 |
|
|
2018
Q1 | $266K | Buy |
3,678
+538
| +17% | +$41K | 0.06% | 312 |
|
|
2017
Q4 | $236K | Buy |
3,140
+49
| +2% | +$3.7K | 0.05% | 327 |
|
|
2017
Q3 | $237K | Buy |
+3,091
| New | +$233K | 0.05% | 333 |
|
|
2017
Q1 | – | Sell |
-3,292
| Closed | -$214K | – | 368 |
|
|
2016
Q4 | $214K | Sell |
3,292
-184
| -5% | -$11.9K | 0.05% | 301 |
|
|
2016
Q3 | $245K | Buy |
3,476
+241
| +7% | +$17.6K | 0.06% | 281 |
|
|
2016
Q2 | $239K | Buy |
3,235
+53
| +2% | +$3.66K | 0.06% | 275 |
|
|
2016
Q1 | $206K | Buy |
3,182
+255
| +9% | +$17.3K | 0.06% | 286 |
|
|
2015
Q4 | $225K | Buy |
2,927
+236
| +9% | +$18.7K | 0.06% | 278 |
|
|
2015
Q3 | $221K | Buy |
2,691
+67
| +3% | +$5.96K | 0.07% | 280 |
|
|
2015
Q2 | $231K | Sell |
2,624
-216
| -8% | -$19.8K | 0.07% | 288 |
|
|
2015
Q1 | $250K | Buy |
2,840
+17
| +0.6% | +$1.51K | 0.07% | 279 |
|
|
2014
Q4 | $234K | Buy |
2,823
+63
| +2% | +$5.22K | 0.07% | 259 |
|
|
2014
Q3 | $233K | Sell |
2,760
-79
| -3% | -$6.39K | 0.08% | 259 |
|
|
2014
Q2 | $230K | Hold |
2,839
| – | – | 0.07% | 269 |
|
|
2014
Q1 | $216K | Sell |
2,839
-3,674
| -56% | -$268K | 0.08% | 239 |
|
|
2013
Q4 | $469K | Sell |
6,513
-190
| -3% | -$13.2K | 0.19% | 127 |
|
|
2013
Q3 | $461K | Sell |
6,703
-5,007
| -43% | -$331K | 0.21% | 123 |
|
|
2013
Q2 | $742K | Buy |
+11,710
| New | +$762K | 0.34% | 80 |
|
Other funds holding NVS
Private Trust Company's NVS Position: Q2 2026 in Review
Private Trust Company reduced its Novartis (NVS) stake by 1.1% in Q2 2026, selling an estimated $10.5K and leaving 6,324 shares worth $991K. The position accounts for 0.08% of the portfolio, ranked #279.
Private Trust Company first reported a position in NVS in Q2 2013 and has held it in 51 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Private Trust Company held 6,324 shares of Novartis worth $991K as of Q2 2026.
- Private Trust Company sold 70 Novartis shares in Q2 2026, an estimated $10.5K.
- Novartis made up 0.08% of Private Trust Company's portfolio in Q2 2026, its #279 holding.
- Private Trust Company first reported a position in Novartis in Q2 2013 and has held it in 51 quarters since.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.